FDA reopens comment period on opioid analgesics abuse The Food and Drug Administration is reopening the comment period for the notice entitled “Center for Drug Evaluation and Research; Use of Innovative Packaging, Storage, and/or Disposal Systems to Address the Misuse and Abuse of Opioid Analgesics,” which published in the Federal Register of April 9. FDA is reopening the comment period to allow interested persons additional time to submit comments, it stated in a notice. Reference Link
News For ZGNX From The Last 14 Days
Check below for free stories on ZGNX the last two weeks.